Prolongation of concordant xenograft survival by treatment with FTY720

By Miyata Y.   Ohdan H.   Noriyuki T.   Shintaku S.   Shibata S.   Yamamoto H.   Fan X.H.   Fudaba Y.   Yoshioka S.   Asahara T.   Fukuda Y.   Dohi K.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4163-4165

Elsevier

Access to resources Recommend Favorite

Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats

By Suzuki S.   Enosawa S.   Kakefuda T.   Li X.-K.   Mitsusada M.   Takahara S.   Amemiya H.  

Transplant Immunology, Vol. 4, Iss. 3, 1996-09 ,pp. : 252-255

Elsevier

Access to resources Recommend Favorite

Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival

By Stepkowski S.M.   Wang M.-e.   Qu X.   Yu J.   Okamoto M.   Tejpal N.   Kahan B.D.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2214-2216

Elsevier

Access to resources Recommend Favorite

FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines

By Chen S.   Bacon K.B.   Garcia G.   Liao R.   Pan Z.K.   Sullivan S.K.   Nakano H.   Matsuzawa A.   Brinkmann V.   Feng L.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3057-3063

Elsevier

Access to resources Recommend Favorite

Prolongation of graft survival in the concordant hamster-to-rat cardiac model

By Brouard S.   Blancho G.   Moreau A.   Heslan J.-M.   Cuturi M.-C.   Soulillou J.P.  

Transplantation Proceedings, Vol. 30, Iss. 5, 1998-08 ,pp. : 2486-2487

Elsevier

Access to resources Recommend Favorite